scholarly journals Characterization of the binding site for nevirapine (BI-RG-587), a nonnucleoside inhibitor of human immunodeficiency virus type-1 reverse transcriptase

1991 ◽  
Vol 266 (22) ◽  
pp. 14670-14674
Author(s):  
K.A. Cohen ◽  
J. Hopkins ◽  
R.H. Ingraham ◽  
C. Pargellis ◽  
J.C. Wu ◽  
...  
FEBS Letters ◽  
1992 ◽  
Vol 312 (2-3) ◽  
pp. 249-251 ◽  
Author(s):  
R.L. Mitina ◽  
S.V. Doronin ◽  
M.I. Dobrikov ◽  
D.R. Tabatadze ◽  
A.S. Levina ◽  
...  

2001 ◽  
Vol 75 (14) ◽  
pp. 6692-6699 ◽  
Author(s):  
Michael B. Zwick ◽  
Lori L. C. Bonnycastle ◽  
Alfredo Menendez ◽  
Melita B. Irving ◽  
Carlos F. Barbas ◽  
...  

ABSTRACT Human monoclonal antibody (MAb) b12 recognizes a conformational epitope that overlaps the CD-4-binding site of the human immunodeficiency virus type 1 (HIV-1) envelope. MAb b12 neutralizes a broad range of HIV-1 primary isolates and protects against primary virus challenge in animal models. We report here the discovery and characterization of B2.1, a peptide that binds specifically to MAb b12. B2.1 was selected from a phage-displayed peptide library by using immunoglobulin G1 b12 as the selecting agent. The peptide is a homodimer whose activity depends on an intact disulfide bridge joining its polypeptide chains. Competition studies with gp120 indicate that B2.1 occupies the b12 antigen-binding site. The affinity of b12 for B2.1 depends on the form in which the peptide is presented; b12 binds best to the homodimer as a recombinant polypeptide fused to the phage coat. Originally, b12 was isolated from a phage-displayed Fab library constructed from the bone marrow of an HIV-1-infected donor. The B2.1 peptide is highly specific for b12 since it selected only phage bearing b12 Fab from this large and diverse antibody library.


Virology ◽  
1997 ◽  
Vol 236 (2) ◽  
pp. 364-373 ◽  
Author(s):  
Miguel E. Quiñones-Mateu ◽  
Vicente Soriano ◽  
Esteban Domingo ◽  
Luis Menéndez-Arias

Sign in / Sign up

Export Citation Format

Share Document